BRAIN and NERVE－神経研究の進歩66巻10号

2014年10月発行

総説

多発性硬化症における認知機能障害

著者： 越智博文¹

所属機関： ¹愛媛大学大学院医学系研究科老年・神経・総合診療内科学

ページ範囲：P.1201 - P.1209

文献概要

多発性硬化症では最大70%の患者に認知機能障害が認められる。注意や情報処理速度，作業記憶の障害が認められやすく，患者の生活の質や社会生活に大きく影響することも少なくない。多発性硬化症患者の認知機能を正しく評価し，認知機能障害に対して介入することは極めて重要であるが，有効性が確立された対処法がないのが現状である。治療研究の発展が期待される。

参考文献

1) Charcot JM: Séance du 14 mars. Comp Rend Soc Biol (Paris) 20: 13-14, 1868

2) Charcot JM: Lectures on the disease of the nervous system. New Sydenham Society, London, 1877

3) McKhann GM: Multiple sclerosis. Annu Rev Neurosci 5: 219-239, 1982

4) Amato MP, Zipoli V, Portaccio E: Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. J Neurol Sci 245(1-2): 41-46, 2006

5) Rao SM: Neuropsychology of multiple sclerosis: a critical review. J Clin Exp Neuropsychol 8: 503-542, 1986

6) Rao SM, Hammeke TA, McQuillen MP, Khatri BO, Lloyd D: Memory disturbance in chronic progressive multiple sclerosis. Arch Neurol 41: 625-631, 1984

7) Rao SM, Leo GJ, Bernardin L, Unverzagt F: Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 41: 685-691, 1991

8) Chiaravalloti ND, DeLuca J: Cognitive impairment in multiple sclerosis. Lancet Neurol 7: 1139-1151, 2008

9) Achiron A, Polliack M, Rao SM, Barak Y, Lavie M, et al: Cognitive patterns and progression in multiple sclerosis: construction and validation of percentile curves. J Neurol Neurosurg Psychiatry 76: 744-749, 2005

10) Amato MP, Ponziani G, Siracusa G, Sorbi S: Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch Neurol 58: 1602-1606, 2001

11) Lyon-Caen O, Jouvent R, Hauser S, Chaunu MP, Benoit N, et al: Cognitive function in recent-onset demyelinating diseases. Arch Neurol 43: 1138-1141, 1986

12) Amato MP, Ponziani G, Pracucci G, Bracco L, Siracusa G, et al: Cognitive impairment in early-onset multiple sclerosis: pattern, predictors, and impact on everyday life in a 4-year follow-up. Arch Neurol 52: 168-172, 1995

13) Zivadinov R, Sepcic J, Nasuelli D, De Masi R, Bragadin LM, et al: A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 70: 773-780, 2001

14) Amato MP, Bartolozzi ML, Zipoli V, Portaccio E, Mortilla M, et al: Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment. Neurology 63: 89-93, 2004

15) Deloire MS, Salort E, Bonnet M, Arimone Y, Boudineau M, et al: Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 76: 519-526, 2005

16) Schulz D, Kopp B, Kunkel A, Faiss JH: Cognition in the early stage of multiple sclerosis. J Neurol 253: 1002-1010, 2006

17) Achiron A, Barak Y: Cognitive impairment in probable multiple sclerosis. J Neurol Neurosurg Psychiatry 74: 443-446, 2003

18) Feuillet L, Reuter F, Audoin B, Malikova I, Barrau K, et al: Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler 13: 124-127, 2007

19) Glanz BI, Holland CM, Gauthier SA, Amunwa EL, Liptak Z, et al: Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis. Mult Scler 13: 1004-1010, 2007

20) Potagas C, Giogkaraki E, Koutsis G, Mandellos D, Tsirempolou E, et al: Cognitive impairment in different MS subtypes and clinically isolated syndromes. J Neurol Sci 267(1-2): 100-106, 2008

21) Jongen PJ, Ter Horst AT, Brands AM: Cognitive impairment in multiple sclerosis. Minerva Med 103: 73-96, 2012

22) Reuter F, Zaaraoui W, Crespy L, Faivre A, Rico A, et al: Frequency of cognitive impairment dramatically increases during the first 5 years of multiple sclerosis. J Neurol Neurosurg Psychiatry 82: 1157-1159, 2011

23) Amato MP, Zipoli V, Goretti B, Portaccio E, De Caro MF, et al: Benign multiple sclerosis: cognitive, psychological and social aspects in a clinical cohort. J Neurol 253: 1054-1059, 2006

24) Ghezzi A, Goretti B, Portaccio E, Roscio M, Amato MP: Cognitive impairment in pediatric multiple sclerosis. Neurol Sci 31(Suppl 2): S215-S218, 2010

25) Huijbregts SC, Kalkers NF, de Sonneville LM, de Groot V, Polman CH: Cognitive impairment and decline in different MS subtypes. J Neurol Sci 245(1-2): 187-194, 2006

26) Beatty WW, Aupperle RL: Sex differences in cognitive impairment in multiple sclerosis. Clin Neuropsychol 16: 472-480, 2002

27) Savettieri G, Messina D, Andreoli V, Bonavita S, Caltagirone C, et al: Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis. J Neurol 251: 1208-1214, 2004

28) Takeda A, Nakajima M, Kobayakawa M, Tsuruya N, Koyama S, et al: Attention deficits in Japanese multiple sclerosis patients with minor brain lesion loads. Neuropsychiatr Dis Treat 7: 745-751, 2011

29) Benedict RH, Bobholz JH: Multiple sclerosis. Semin Neurol 27: 78-85, 2007

30) Niino M, Mifune N, Kohriyama T, Mori M, Ohashi T, et al: Apathy/depression, but not subjective fatigue, is related with cognitive dysfunction in patients with multiple sclerosis. BMC Neurol 14: 3, 2014

31) Minden SL: Mood disorders in multiple sclerosis: diagnosis and treatment. J Neurovirol 6(Suppl 2): S160-S167, 2000

32) Siegert RJ, Abernethy DA: Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatry 76: 469-475, 2005

33) Arnett PA, Barwick FH, Beeney JE: Depression in multiple sclerosis: review and theoretical proposal. J Int Neuropsychol Soc 14: 691-724, 2008

34) Calabrese M, Rinaldi F, Grossi P, Mattisi I, Bernardi V, et al: Basal ganglia and frontal/parietal cortical atrophy is associated with fatigue in relapsing-remitting multiple sclerosis. Mult Scler 16: 1220-1228, 2010

35) Rao SM, Leo GJ, Haughton VM, St Aubin-Faubert P, Bernardin L: Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology 39(2 Pt 1): 161-166, 1989

36) Rossi F, Giorgio A, Battaglini M, Stromillo ML, Portaccio E, et al: Relevance of brain lesion location to cognition in relapsing multiple sclerosis. PLOS ONE 7: e44826, 2012

37) Benedict RH, Carone DA, Bakshi R: Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis. J Neuroimaging 14(3 Suppl): 36S-45S, 2004

38) Benedict RH, Bruce JM, Dwyer MG, Abdelrahman N, Hussein S, et al: Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis. Arch Neurol 63: 1301-1306, 2006

39) Tekok-Kilic A, Benedict RH, Weinstock-Guttman B, Dwyer MG, Carone D, et al: Independent contributions of cortical gray matter atrophy and ventricle enlargement for predicting neuropsychological impairment in multiple sclerosis. NeuroImage 36: 1294-1300, 2007

40) Swirsky-Sacchetti T, Mitchell DR, Seward J, Gonzales C, Lublin F, et al: Neuropsychological and structural brain lesions in multiple sclerosis: a regional analysis. Neurology 42: 1291-1295, 1992

41) Hulst HE, Steenwijk MD, Versteeg A, Pouwels PJ, Vrenken H, et al: Cognitive impairment in MS: impact of white matter integrity, gray matter volume, and lesions. Neurology 80: 1025-1032., 2013

42) Dineen RA, Vilisaar J, Hlinka J, Bradshaw CM, Morgan PS, et al: Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis. Brain 132(Pt 1): 239-249, 2009

43) Iannucci G, Tortorella C, Rovaris M, Sormani MP, Comi G, et al: Prognostic value of MR and magnetization transfer imaging findings in patients with clinically isolated syndromes suggestive of multiple sclerosis at presentation. AJNR Am J Neuroradiol 21: 1034-1038, 2000

44) Filippi M, Tortorella C, Rovaris M, Bozzali M, Possa F, et al: Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis. J Neurol Neurosurg Psychiatry 68: 157-161, 2000

45) Staffen W, Zauner H, Mair A, Kutzelnigg A, Kapeller P, et al: Magnetic resonance spectroscopy of memory and frontal brain region in early multiple sclerosis. J Neuropsychiatry Clin Neurosci 17: 357-363, 2005

46) Caramia F, Tinelli E, Francia A, Pozzilli C: Cognitive deficits in multiple sclerosis: a review of functional MRI studies. Neurol Sci 31(Suppl 2): S239-S243, 2010

47) Audoin B, Au Duong MV, Ranjeva JP, Ibarrola D, Malikova I, et al: Magnetic resonance study of the influence of tissue damage and cortical reorganization on PASAT performance at the earliest stage of multiple sclerosis. Hum Brain Mapp 24: 216-228, 2005

48) Portaccio E, Goretti B, Zipoli V, Siracusa G, Sorbi S, et al: A short version of Rao's Brief Repeatable Battery as a screening tool for cognitive impairment in multiple sclerosis. Clin Neuropsychol 23: 268-275, 2009

49) Benedict RH, Fischer JS, Archibald CJ, Arnett PA, Beatty WW, et al: Minimal neuropsychological assessment of MS patients: a consensus approach. Clin Neuropsychol 16: 381-397, 2002

50) Rao SM: A Manual for the Brief Repeatable Battery of Neuropsychological Tests in Multiple Sclerosis. Medical College of Wisconsin, Milwaukee, 1990

51) Rao SM, Leo GJ, Ellington L, Nauertz T, Bernardin L, et al: Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 41: 692-696, 1991

52) Benedict RH, Cookfair D, Gavett R, Gunther M, Munschauer F, et al: Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc 12: 549-558, 2006

53) Strober L, Englert J, Munschauer F, Weinstock-Guttman B, Rao S, et al: Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS. Mult Scler 15: 1077-1084, 2009

54) Langdon DW, Amato MP, Boringa J, Brochet B, Foley F, et al: Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult Scler 18: 891-898, 2012

55) Amato MP, Langdon D, Montalban X, Benedict RH, DeLuca J, et al: Treatment of cognitive impairment in multiple sclerosis: position paper. J Neurol 260: 1452-1468, 2013

56) Kappos L, Polman CH, Freedman MS, Edan G, Hartung HP, et al: Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology 67: 1242-1249, 2006

57) Cohen JA, Barkhof F, Comi G, Hartung HP, Khatri BO, et al: Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med 362: 402-415, 2010

58) Kappos L, Radue EW, O'Connor P, Polman C, Hohlfeld R, et al: A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med 362: 387-401, 2010